medigraphic.com
Centro Universitario de Ciencias de la Salud de la Universidad de Guadalajara y del OPD Hospitales Civiles de Guadalajara

2006, Number 2

<< Back Next >>

Inv Salud 2006; 8 (2)

Genomic medicine and hepatology

Panduro A, Roman S, Escobedo G

Language: Spanish
References: 46
Page: 105-111
PDF size: 292.50 Kb.


ABSTRACT

This Paper is an authors view on genomic medicine and hepatology. The study begins with a reflection derived from the Digestive Disease Week (American Association of Gastroenterology) celebrated in Los Angeles, California, USA in May 2006. A brief summary is presented about the historical process of medicine with emphasis on scientific medicine. Further on it describes over time until our present days, the developmental process of science in the field of viral hepatitis, with the study of hepatitis B virus. It concludes with a summary of the advances in genomic medicine that in hepatology were given at the meeting and reflection about the necessity to change pre and postgraduate Mexican programs in health sciences in order to re-orientate this new knowledge towards health care professionals with the new profile in genomic medicine.


REFERENCES

  1. McDonald S. Acute yellow atrophy. Edinb. Med. J. 1908;15:208

  2. Findlay GM and co-workers. Observation on epidemic catarrhal jaundice. Trans. R. Soc. Trop. Med. Hyg. 1931 ;25 :7-28.

  3. Editorial. Jaundice following yellow fever vaccination. JAMA. 1943;119:1110

  4. Hipocrates: KDe Morbus Intemis in Oeuvres Complètes. Vol 7. pp 237-243

  5. Schmid R. History of Viral Hepatitis: A tale of dogmas and misinterpretations. Journal of gastroenterology and hepatology. 2001;16:718-22

  6. MacCallum FO. Historical perspectives. Can. Med. Assoc. J. (Special Issue). 1972;106:423

  7. Patlak M. The hepatitis B story. National Academy of Sciences, 2000. Aviable at: www.beyonddiscovery.org

  8. Virchow R. Ueber das Vorckommen und den Nachweis des Hepatogenen, insbesondere des katarrhalischen Icterus. Virchow’s Arch Abt Pathol Anat. 1864;32:117

  9. Lyon, BB Vicent. Non-surgical drainage of the gall tract. Philadelphia, Lea and Febiger. 1923

  10. MacCallum FO, Bradley WH. Transmission of infective hepatitis to human volunteers. Lancet. 1944;2:228

  11. Neefe JR, Stokes Jr J, Gellis SS. Homologous serum hepatitis and infectious (epidemic) hepatitis. Am. J. Med. Sci. 1945;210:561-75

  12. Blumberg BS, Alter HJ, Vinish S. A “New” Antigen in Leukemia Sera. JAMA. 1965;191(7):101-106

  13. Blumberg BS. Australia Antigen and the Biology of Hepatitis B. Science. 1977;197:17-25

  14. Blumberg Baruch. Hepatitis B virus, the vaccine, and control of primary cancer of the liver. Proc Natl Acad Sci USA. 1997;94:7121-25

  15. Prince AM. An antigen detected in the blood during the incubation period of serum hepatitis. Proc. Natl. Acad. Sci. USA. 1968;60:814-21

  16. Okochi K, Murakami S. Observations on Australian antigen in Japanese. Vox sang. 1968;15:374-85

  17. Gocke DJ, Kavey NB. Hepatitis antigen. Correlation with disease and infectivity of blood-donors. Lancet. 1969;1:1055-9

  18. Menghini G. One-second needle biopsy of the liver. Gastroenterology. 1958;35:190

  19. Beesib PB. The growth of knowledge about a disease: hepatitis. American Journal Medicine. 1979;67:366

  20. Alter HJ, Purcell RH, Feinstone SM, Holland PV, Morrow AG. Non-A/non-B hepatitis: A review and interim report of an ongoing prospective study. In: Vyas GN, Cohen SN, Schmid R, eds. Viral Hepatitis. Philadelphia: The Franklin Institute Press. 1978;359-69

  21. Dane DS, Cameron CH, Briggs M. Virus-like particles in serum of patients with Australia-antigen-associated hepatitis. Lancet. 1970;1:695-8

  22. Purcell RH, Gerin JL. Hepatitis B vaccines: A status report. In: Vyas GN, Cohen SN, Schmid R, eds. Viral Hepatitis. Philadelphia: The Franklin Institute Press. 1978;491-505

  23. Szmuness W, Alter HJ, Maynard JE, eds. Viral Hepatitis, 1981, International Symposium. Philadelphia: The Franklin Institute Press. 1982

  24. Krugman S, Giles JP, Hammond J. Infectious Hepatitis. Evidence for Two Distintive Clinical, Epidemiological, and Immunological Types Infection. JAMA. 1967;200(5):95-103

  25. Krugman S, Giles JP. Viral Hepatitis. New Light on an Old Disease. JAMA. 1970;212(6):119-29

  26. Krugman S, Giles JP, Hammond J. Viral Hepatitis, Type B (MS-2 Strain) Studies On Active Immunization. JAMA. 1971;217(1):41-45

  27. Krugman S, Giles JP. Viral Hepatitis, Type B (MS-2 Strain) Further Observations on Natural History and Prevention. The New England Journal of Medicine. 1973;288(15):755-760

  28. SchiffL. Jaundice: Five-and-a-half Decadas in Historic Perspective. Selected Aspects. Gastroenterology. 1980;73:831-36

  29. Almeida JD, Rubenstein D, Stott EJ : New antigen-antibody system in Australia-antigen-positive hepatitis. Lancet. 1971 ;2 :1225-1226

  30. Magnius LO, Espmark A : A new antigen complex co-occurring with Australia antigen. Acta Pathol Microbiol Scand B. 1972;80:335-337

  31. Krugman S, Overby LR, Mushahwar IK et al: Viral hepatitis, type B. Studies on natural history and prevention re-examined. N Engl J Med. 1979;300:101-106

  32. Purcell RH: The discovery of the hepatitis viruses. Gastroenterology. 1993;104:955-963

  33. Burrell CJ, Mackay P, Greenaway PJ: Expression in E coli of HBV sequences cloned in plasmid pBR-322 Nature 1979;279:43-47

  34. Monjardino J, Fowler MJF, Montano L, et al: Analysis of hepatitis virus DNA in the liver and serum of HBe antigen positive chimpanzee carriers. J Med Virol 1982;9:189-199

  35. Arturo Panduro. Cromosomas, DNA y genes. Biología Molecular en la Clínica. Ed. McGraw-Hill Interamericana. 2000;3-9

  36. Arturo Panduro, Blanca E. Bastidas-Ramírez y Patricia Nuño. DNA recombinante, sondas y técnicas elementales de biología molecular. Biología Molecular en la Clínica. Ed. McGraw-Hill Interamericana. 2000;11-21

  37. Szmuness W. Hepatocellular carcinoma and the hepatitis B virus: evidence for a causal association. Prog. Med. Virol. 1978;24:40-69

  38. Szmuness W. Stevens C.E. Harley E.J. et al. Hepatitis B vaccine demonstration of efficacy in a controlled clinical trial in a high risk population in the United States. N. Engl. J. Med. 1980;303:833-41

  39. Shafritz David A., M.D., Daniel Shouval, M.D., Howard I. Sherman, M.D., Stefanos J. Hadziyannis, M.D., and Michael C. Kew, M.D. Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver desease and hepatocellular carcinoma. The New England Journal of Medicine. 1981;305(18):1067-1073

  40. Summers J, Mason WS. Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate. Cell. 1982;29:403-415

  41. Gust I.D. Towards the control of hepatitis B: An historical review. Aust. Paediatr. J. 1986;22:273-276

  42. Chang MH, Chen CJ, Lai MS, et al. Universal hepatitis B vaccination in Taiwan Childhood Hepatoma Study Group. N. Engl. J Med. 1997;336:1855-185943. MichalakTI, Pasquinelli C, Guilhot S. et al. Hepatitis B virus persistence after recovery from acute viral hepatitis. J Clin Invest. 1994;93:230-239

  43. Sonia M. Román-Maldonado, Arturo Panduro. Medicina genómica: Curriculum y formación de recursos humanos en salud. Revista de Investigación en Salud. Agosto 2005;Vol.VII(2):98-104 Carlos Larracilla/Otra lección de anatomía

  44. Arturo Panduro, Sonia M. Román-Maldonado. La investigación científica en las instituciones de educación superior del país. Revista de Investigación en Salud. Abril 2005;Vol.VII(1):38-41

  45. Arturo Panduro. Servicio de Biología Molecular en Medicina. OPD Hospital Civil de Guadalajara. Universidad de Guadalajara. Centro Universitario de Ciencias de la Salud. Editorial Pandora, S.A. de C.V. 2002;Noviembre:1-55

  46. Arturo Panduro. Guía académica del Doctorado en Biología Molecular en Medicina. Medicina Genómica. Universidad de Guadalajara. Centro Universitario de Ciencias de la Salud. Departamento de Fisiología. División de Disciplinas Básicas. Editorial Pandora, S.A. de C.V. 2002;Noviembre:1-65




2020     |     www.medigraphic.com